Related Experiment Video
Updated: Mar 18, 2026

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Insights from a multidisciplinary heart team for highest-risk valve disease
Taylor Pickering1, John Eisenga1, Kyle McCullough1
1Baylor Scott & White Research Institute, Plano, Texas, USA.
Insights
Multidisciplinary heart team (MHT) evaluation guides treatment for complex valvular heart disease (VHD) patients. This approach helps select appropriate interventions, improving outcomes for high-risk individuals.
Area of Science:
- Cardiology
- Cardiac Surgery
- Interventional Cardiology
Background:
- Multidisciplinary heart team (MHT) evaluation is recommended for complex valvular heart disease (VHD).
- Limited outcomes data exist for high-risk VHD patients undergoing surgical referral.
- MHTs integrate diverse specialists for comprehensive patient assessment.
Purpose of the Study:
- To analyze the outcomes of high-risk or complex VHD patients evaluated by an institutional MHT.
- To assess the impact of MHT recommendations on patient management and survival.
Main Methods:
- Prospective evaluation of 121 high-risk/complex VHD patients from June 2021 to August 2022.
- MHT included cardiac surgeons, interventional cardiologists, heart failure specialists, imaging, intensivists, and palliative care.
- Data collected: demographics, risk scores, treatment plans, MHT recommendations, adherence, readmissions, and mortality at 30 days, 1 year, and 2 years.
Main Results:
- MHT recommended surgery for 67%, transcatheter intervention for 14%, hybrid for 3%, and medical management for 17%.
- Overall adherence to MHT recommendations was 89%.
- Two-year mortality varied: surgery 21%, transcatheter 53%, hybrid 33%, medical management 55%.
Conclusions:
- MHT evaluation enables personalized treatment strategies for complex VHD.
- It identifies patients who benefit from intervention despite high risk.
- It also spares patients unlikely to benefit from aggressive treatments.
Background:
Multidisciplinary heart team (MHT) evaluation is a class I recommendation for coronary and structural heart disease, yet limited outcomes data exist for high-risk and complex valvular heart disease (VHD) patients referred for surgery.
Methods:
From June 2021 to August 2022, our institutional MHT-comprising cardiac surgeons, interventional cardiologists, heart failure specialists, advanced imaging specialists, intensivists, and palliative care specialists-evaluated the highest-risk or complex VHD patients. Patient demographics, Society of Thoracic Surgeons Predicted Risk of Mortality scores, initial treatment plans, final team recommendations, and outcomes, including adherence to recommendations, 30-day readmission, and mortality at 30 days, 1 year, and 2 years were analyzed.
Results:
Among 121 patients, the MHT recommended surgery for 67%, transcatheter intervention for 14%, a hybrid approach for 3%, and medical management (MM) for 17%. Overall adherence to MHT recommendations was 89%. Thirty-day mortality was 7/81 (9%) for surgical patients, 3/17 (18%) for transcatheter, 0/3 for hybrid, and 4/20 (20%) for MM. By 2 years, mortality rose to 17/81 (21%) for surgery, 9/17 (53%) for transcatheter, 1/3 (33%) for hybrid, and 11/20 (55%) for MM.
Conclusion:
MHT evaluation facilitates individualized treatment strategies by distinguishing patients who may benefit from intervention despite high procedural risk, while sparing those unlikely to benefit.
Related Concept Videos
Mitral Stenosis IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management

